447 related articles for article (PubMed ID: 35664731)
1. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics.
Zhou L; Zou M; Xu Y; Lin P; Lei C; Xia X
Front Oncol; 2022; 12():864301. PubMed ID: 35664731
[TBL] [Abstract][Full Text] [Related]
2. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
3. Cancer Immunotherapy and Delivery System: An Update.
Yang M; Olaoba OT; Zhang C; Kimchi ET; Staveley-O'Carroll KF; Li G
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015256
[TBL] [Abstract][Full Text] [Related]
4. Delivery technologies for cancer immunotherapy.
Riley RS; June CH; Langer R; Mitchell MJ
Nat Rev Drug Discov; 2019 Mar; 18(3):175-196. PubMed ID: 30622344
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for advanced cancer immunotherapy.
Diep YN; Kim TJ; Cho H; Lee LP
J Control Release; 2022 Nov; 351():1017-1037. PubMed ID: 36220487
[TBL] [Abstract][Full Text] [Related]
6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
7. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects.
Chen J; Cong X
Biomed Pharmacother; 2023 Jan; 157():113998. PubMed ID: 36399829
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology Approaches to Improving Cancer Immunotherapy.
Hagan CT; Medik YB; Wang AZ
Adv Cancer Res; 2018; 139():35-56. PubMed ID: 29941106
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors.
Zhang J; Wang S; Zhang D; He X; Wang X; Han H; Qin Y
Front Immunol; 2023; 14():1230893. PubMed ID: 37600822
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective.
Allegra A; Gioacchino MD; Tonacci A; Petrarca C; Gangemi S
Nanomaterials (Basel); 2021 Oct; 11(11):. PubMed ID: 34835555
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy.
Kim J; Hong J; Lee J; Fakhraei Lahiji S; Kim YH
J Control Release; 2021 Apr; 332():109-126. PubMed ID: 33571549
[TBL] [Abstract][Full Text] [Related]
13. Light-responsive nanomedicine for cancer immunotherapy.
Kang W; Liu Y; Wang W
Acta Pharm Sin B; 2023 Jun; 13(6):2346-2368. PubMed ID: 37425044
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine-Combined Immunotherapy for Cancer.
Huang S; Zhao Q
Curr Med Chem; 2020; 27(34):5716-5729. PubMed ID: 31250752
[TBL] [Abstract][Full Text] [Related]
15. Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells.
Yong SB; Chung JY; Song Y; Kim J; Ra S; Kim YH
Biomaterials; 2019 Oct; 219():119401. PubMed ID: 31398571
[TBL] [Abstract][Full Text] [Related]
16. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
Tyagi P; Subramony JA
J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
[TBL] [Abstract][Full Text] [Related]
17. Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy.
Li J; Zeng H; Li L; Yang Q; He L; Dong M
ACS Nano; 2023 Dec; 17(24):24593-24618. PubMed ID: 38055350
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
19. The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment.
Li H; Fu Q; Muluh TA; Shinge SAU; Fu S; Wu J
Recent Pat Anticancer Drug Discov; 2023; 18(1):53-65. PubMed ID: 35260063
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications.
Wu P; Han J; Gong Y; Liu C; Yu H; Xie N
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
